# Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy

Study · id `cardio:ct-nct04562714` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04562714](<https://clinicaltrials.gov/study/NCT04562714>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04562714

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

## Technical summary

Registry record NCT04562714. Randomized; no masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2022-09-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 116 participants (enrolled count; ClinicalTrials.gov record NCT04562714, source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)
- Started: 2020-09-08 (actual) (ClinicalTrials.gov record NCT04562714, source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)
- Primary completion: 2022-09-06 (actual) (ClinicalTrials.gov record NCT04562714, source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)
- Completion: 2022-09-06 (actual) (ClinicalTrials.gov record NCT04562714, source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04562714, source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04562714-2023-11-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
- Acronym: IMMEDIATE
- Condition: Diabetes Mellitus, Type 2
- Condition: Glucose
- Intervention (Device): FreeStyle Libre Flash Glucose Monitor
- Intervention (Other): Diabetes self-management education
- Lead sponsor: LMC Diabetes & Endocrinology Ltd.
- Lead sponsor class: OTHER
- Collaborator: Abbott Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: LMC Diabetes & Endocrinology Ltd. (`cardio:org-lmc-diabetes-endocrinology-ltd`)
- Registry lists this organization as a collaborator: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: d7b65f173b64a5c5b1471b0dc9948e936371dc1d71c7c90f685eec1d51e5f531
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
